🇺🇸 FDA
Pipeline program

Azvudine

IBR2022072

Unknown small_molecule active

Quick answer

Azvudine for SARS-CoV-2 Infection is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
SARS-CoV-2 Infection
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials